TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CTRE

CTRE

CareTrust REIT, Inc.

Next earnings Aug 4, 2026 · consensus $0.37 EPS, $129M rev

Last earnings +0.1% on 2026-05-07

Buy
$41.76
▲ +3.19%
$41.76▲ +42.13%
over 1Y
L $29.38H $42.44
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.2%
1W+4.9%
1M+7.8%
3M+9.0%
YTD+16.2%
1Y+42.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B+
Valuation
Undervalued
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 17 analysts
Buy

Fast-growing healthcare triple-net REIT with near-100% rent collection, a rising dividend and low leverage, expanding into the UK.

Net income (FY2025) $321M · FY2025

The read

Quality fundamentals and an attractive price line up (~43% below fair value) — the rarer case where both the business and the entry look good.

CareTrust REIT is a self-administered healthcare REIT owning skilled-nursing facilities, senior-housing communities and related properties — 407 properties with 37,628 operational beds/units across 32 U.S. states and the U.K. as of year-end 2025. FY2025 was a major growth year: net income surged 156.3% to $321M and diluted EPS rose 96.3% to $1.57, while total assets jumped 49.8% to $5.15B, driven by acquisitions including the $595.4M Care REIT plc (UK) deal and the establishment of a RIDEA senior-housing operating (SHOP) platform. Operating cash flow grew 61.3% to $394M, underpinning a 50.6%-larger dividend of $259M. (Note the $1.23M XBRL 'revenue' figure is a tagging artifact for a triple-net REIT whose income is overwhelmingly rental; the operating metrics and MD&A rent disclosures are the relevant reads.)

The portfolio is performing well. Management reports collecting 100% of contractual rents in Q4 and 99.7% for the full year — strong rent coverage that validates the underwriting in a sector (skilled nursing) often viewed as higher-risk. The balance sheet is conservative for a growth REIT: total liabilities of just $1.09B and long-term debt of $894M against $4.04B equity (0.27x liabilities/equity), giving CareTrust ample capacity to keep funding accretive acquisitions. It also holds $899.3M of real-estate-related loans and preferred-equity investments, a diversified income stream beyond owned real estate.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 5:01 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$0.00$0.00$0.00$0.00$1.23M
Gross profit—————
Operating income—————
Net income$72.0M-$7.51M$53.7M$125M$321M
Diluted EPS$0.74-$0.08$0.50$0.80$1.57
Net margin————26166.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF25.2
PEG (trailing)0.17
Earnings yield3.2%
FCF yield4.0%

Quality & risk

ROIC (est.)—
Free cash flow$391M
Total debt$894M
Net cash-$696M
Piotroski F-Score5/7

Capital returns

Buyback yield—
Dividend yield (est.)2.6%
Shareholder yield2.6%
Shares Δ YoY+19.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Other event2026-05-21
  2. 8-K Other event2026-05-20
  3. 8-K Earnings results2026-05-07
  4. 10-Q Quarterly report2026-05-07
  5. 8-K Shareholder vote2026-04-30
  6. DEF 14A Proxy statement2026-03-13
  7. 8-K Reg FD disclosure2026-03-02
  8. 8-K Material agreement2026-02-18
  9. 10-K Annual report2026-02-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-05-202026-05-21open ↗8-KPeriod ending 2026-05-182026-05-20open ↗424B5Filing2026-05-20open ↗424B5Filing2026-05-18open ↗SCHEDULE 13G/AFiling2026-05-15open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-05-07open ↗8-KPeriod ending 2026-04-292026-04-30open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13GFiling2026-04-29open ↗SCHEDULE 13G/AFiling2026-04-24open ↗SCHEDULE 13G/AFiling2026-03-26open ↗

Quality score

B+
ValueGrowthProfitHealthMom.
ValueF
GrowthA+
ProfitabilityB+
Financial healthA-
MomentumA+
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$59.66

Undervalued +43% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.57 × (8.5 + 1.5 × 22.0% growth) × 0.95 quality = 38.0× multiple. An estimate, not a price target.

29.1252-week42.03
Revenue
$1.23M
Net margin
26166.4%
ROE
7.9%
P/E
26.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.23M
Net income$321M+156.3%
Diluted EPS$1.57+96.3%
Cash & equivalents$198M-7.4%
Total assets$5.15B+49.8%
Total liabilities$1.09B+114.6%
Stockholders' equity$4.04B+38.7%
L/E: 0.27x

Frequently asked

Is CareTrust REIT, Inc. (CTRE) a buy?
CTRE currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Fast-growing healthcare triple-net REIT with near-100% rent collection, a rising dividend and low leverage, expanding into the UK.
What is CTRE's fair value?
A Modified-Graham model based on CTRE's SEC fundamentals estimates a fair value of about $59.66. It is an estimate from reported earnings, not a price target.
Is CTRE overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CTRE currently appears undervalued relative to its SEC-grounded earnings power.
What is CareTrust REIT, Inc.'s quality score?
CTRE scores 75.30768726412592/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001590717, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/21/2026, 9:01:53 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-01-31
BEALE LAUREN
Chief Accounting Officer
Tax12.2K @ $37.34$456K
2026-01-31
Callister James
CIO and Secretary
Award58.4K
2026-01-31
Callister James
CIO and Secretary
Tax46.3K @ $37.34$1.73M
2026-01-31
Sedgwick David M.
President and CEO
Award99.2K
2026-01-31
Sedgwick David M.
President and CEO
Tax114K @ $37.34$4.27M

Dividends

Quarterly
Yield (TTM)
3.5%
Annual / share
$1.45
Last ex-date
2026-06-30
Last amount
$0.39
ex 2026-06-30paid 2026-07-15$0.39
ex 2026-03-31paid 2026-04-15$0.39
ex 2025-12-31paid 2026-01-15$0.34
ex 2025-09-30paid 2025-10-15$0.34
ex 2025-06-30paid 2025-07-15$0.34
ex 2025-03-31paid 2025-04-15$0.34

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-07Miss -2.3% est▲ +0.05%8-K ↗
2026-02-12Beat +36.7% est▲ +1.90%8-K ↗
2025-11-05Miss -4.2% est▲ +1.72%8-K ↗
2025-08-06Beat +0.4% est▼ -0.43%8-K ↗
2025-05-01—▼ -0.68%8-K ↗
2025-02-12—▼ -0.66%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2023-08-13Daniel GoldmanSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
CareTrust REIT declares $0.39 dividendBullish
seekingalpha.com· 2026-06-16
CareTrust REIT Announces Quarterly Dividend of $0.39 per ShareBullish
finance.yahoo.com· 2026-06-16
Automatic Data Processing And 2 Other Reliable Dividend Stocks To ConsiderBullish
finance.yahoo.com· 2026-06-15
Preferred Bank And 2 Other Dividend Stocks To Boost Your PortfolioBullish
finance.yahoo.com· 2026-06-15
Real estate stocks continue to post gains, outperform broader marketsBullish
seekingalpha.com· 2026-06-13
3 Dividend Stocks To Consider With Yields Up To 5.1%Bullish
finance.yahoo.com· 2026-06-12

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score75 vs 67
Revenue growth— vs 7.5%
Net margin26166.4% vs 10.0%
Return on equity7.9% vs 12.0%
P/E26.6 vs 26.2

News sentiment

EODHD · 14d
Bullish
+0.17
vs typical · 18 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.